Join
Live feed
·
PRReleasevia Quantisnow
Femasys Inc. logo

Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment

ByQuantisnow·Wall Street's wire, on your screen.
FEMY· Femasys Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FEMY (Femasys Inc.) and more on Quantisnow.